A Phase 1, Open-label, Positron Emission Tomography (PET) Trial to Measure Serotonin 5-HT2A Receptor Occupancy Following Single Oral Doses of MSP-2020 in Healthy Male Adults
Latest Information Update: 03 Mar 2026
At a glance
- Drugs MSP 2020 (Primary)
- Indications Mental disorders
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical Development & Commercialization
Most Recent Events
- 27 Feb 2026 Planned End Date changed from 25 Oct 2026 to 11 Feb 2027.
- 27 Feb 2026 Planned primary completion date changed from 12 Oct 2026 to 29 Jan 2027.
- 27 Feb 2026 Status changed from not yet recruiting to recruiting.